A pre-planned subset analysis using a polymorphism of the superoxide dismutase-2 (SOD2) gene as a biomarker shows promising results in the 25% of men with the Alanine/Alanine genotype of SOD2
Our services translate scientific discoveries into improved standards of care, ensuring efficient trial selection, reporting, site management, clinical operations and data analyses.